HealthRevolution

The Depression Treatment Puzzle: Why Therapy and Medication May Work Equally Well—and What That Means for Millions of Patients
For decades, the debate over whether psychotherapy or antidepressant medication is the superior treatment for depression has consumed clinicians, researchers, and patients al...
Read More
Your Headphones May Be Leaching Hormone-Disrupting Chemicals Into Your Skin, and the Doses Are Alarmingly High
For millions of people around the world, headphones are as essential as a wallet or a set of keys. They accompany us on commutes, during workouts, through long work sessions,...
Read More
The Slow Poisoning of America: How Ultra-Processed Foods Became the Nation’s Deadliest Dietary Threat
The United States spends more on health care per capita than any other developed nation, yet its citizens die younger, suffer more chronic disease, and grow sicker with each...
Read More
Jay Bhattacharya’s Expanding Empire: How One Controversial Figure Came to Control Both the NIH and CDC Simultaneously
In an unprecedented consolidation of authority over the nation's public health apparatus, Dr. Jay Bhattacharya — the Stanford economist-turned-NIH director who became one of...
Read More
The $4 Billion Blue Light Glasses Industry Is Built on a Myth — And the Science Has Known for Years
For nearly a decade, opticians, tech accessory companies, and wellness influencers have promoted blue light filtering glasses as essential armor against the digital age. The...
Read More
Garmin’s Quiet Bet on Blood Sugar Monitoring: A Patent That Could Reshape the Wearable Health Market
For years, the holy grail of wearable health technology has been a reliable, non-invasive way to measure blood glucose levels. Now, Garmin — a company better known for GPS de...
Read More
Moderna’s mRNA Flu Vaccine Gets a Second Life: Inside the FDA’s Stunning Reversal and What It Means for the Future of Influenza Prevention
In a remarkable turn of events that has sent ripples through the pharmaceutical industry and public health circles alike, the U.S. Food and Drug Administration has reversed c...
Read More
Monsanto’s $10.9 Billion Roundup Settlement: The Largest Toxic Tort Resolution in American History Takes Shape
Bayer AG's Monsanto unit announced a sweeping class settlement agreement designed to resolve both current and future claims alleging that its flagship herbicide Roundup cause...
Read More
Apple’s Health Intelligence Push: iOS 26.4 Brings Average Bedtime Vitals, Blood Oxygen Restoration, and a Deeper Commitment to Wearable Wellness
Apple Inc. is preparing to release iOS 26.4, a software update that promises to meaningfully expand the health-monitoring capabilities of the Apple Watch and iPhone ecosystem...
Read More
Amazon Pharmacy’s Audacious Same-Day Delivery Expansion Puts Traditional Drugstores on Notice
Amazon is making its most aggressive move yet into the American pharmacy business, announcing plans to expand same-day prescription delivery to nearly 4,500 cities and towns...
Read More
The Quiet Revolution in the Therapist’s Office: How AI Is Reshaping Clinical Thinking Before a Single Word Is Spoken to Patients
For decades, the private intellectual labor of clinical psychologists — the careful formulation of diagnoses, the weighing of treatment modalities, the synthesis of research...
Read More
The Hidden Ecological Price of Ozempic: How the GLP-1 Boom Is Fueling an Environmental Crisis in Our Waterways
The miracle weight-loss drugs that have captivated the world — reshaping bodies, balance sheets, and the pharmaceutical industry — may be leaving behind a toxic legacy that s...
Read More
The 11-Cent Brain Game That Could Slash Dementia Risk by 29%: Inside the Science of Double Decision Training
For decades, the quest to prevent dementia has been dominated by pharmaceutical companies spending billions on drug candidates that, more often than not, fail in clinical tri...
Read More
The FDA Draws a Hard Line: Inside the Federal Crackdown on Compounded GLP-1 Weight-Loss Drugs
The era of loosely regulated compounded versions of blockbuster weight-loss drugs like semaglutide and tirzepatide may be coming to an abrupt end. The U.S. Food and Drug Admi...
Read More
Sugar Rush to Sugar Crash: Why America’s Dessert Chains Keep Rising, Gorging on Growth, and Collapsing
The American dessert industry has a recurring problem: it keeps eating itself alive. From the frozen yogurt boom of the early 2010s to the cupcake craze that preceded it, and...
Read More

Subscribe for Updates

HealthRevolution Newsletter

By signing up for our newsletter you agree to receive content related to ientry.com / webpronews.com and our affiliate partners. For additional information refer to our terms of service.
Get the WebProNews newsletter delivered to your inbox

Get the free daily newsletter read by decision makers

Subscribe
Advertise with Us

Ready to get started?

Get our media kit

Advertise with Us